Chronic Pelvic Pain / Endometriosis Dr Cathy Burke MSc Programme November 2009.
-
Upload
terence-summers -
Category
Documents
-
view
224 -
download
2
Transcript of Chronic Pelvic Pain / Endometriosis Dr Cathy Burke MSc Programme November 2009.
Chronic Pelvic Pain / Endometriosis
Dr Cathy Burke
MSc Programme
November 2009
Chronic Pelvic PainDefinitionVarious definitionsIntermittent or chronic pain in the lower abdomen or pelvis of at least six months duration, not occurring exclusively with menstruation or intercourse and not associated with pregnancy
CPP - Prevalence
• Prevalence in primary care comparable to migraine, back pain and asthma
• Yearly prevalence 38.3/1000 Zondervan 1999
• Most common indication for referral to gynae outpatient clinics - 20% of referrals Howard 1993
• 61% of women with pelvic pain did not have a clear diagnosis Mathias 1996
Dysmenorrhea - risk factorsINCREASED RISK
• Age <30• Being thin (BMI <20)• Smoking (increased with no.
of cigs)• Early menarche• Longer cycles• Heavy / irreg bleeding• Premenstrual sxs• Clinically suspected PID• Sterilisation• Hx of sexual assaultBMJ Feb 2006
DECREASED RISK• Oral contraceptive use• Fish intake• Physical exercise• Being married or in a
stable relationship• Higher parity
Dyspareunia - risk factors
• Hx of circumcision• Clinically suspected PID• Peri-postmenopausal• Anxiety / depression• Sexual assault
BMJ Feb 2006
Non-cyclical pain - risk factors
• Previous miscarriage• Longer menstrual flow• Endometriosis• Clinically suspected PID• Caesarean section• Pelvic adhesions• Physical / sexual / other abuse• Anxiety / depression• Somatisation
BMJ Feb 2006
CPP - Causes
• Pelvic inflammatory disease• Post-surgical adhesions• Irritable bowel syndrome• Constipation• Endometriosis• Interstitial cystitis / recurrent UTI• Psychological morbidity• History of childhood / adult sexual abuse• Pelvic congestion syndrome• Adenomyosis
CPP - History takingPain details• Location • Cyclicity• Timing• Character • Duration• Intensity (score out of 10)• Aggravating / relieving factors• What has / has not worked to date
CPP - History taking
• Dysmenorrhea• Dyspareunia (superficial, deep)• Dyschezia (difficulty, pain), rectal bleeding• Urinary symptoms, haematuria• Non-cyclical pain• Periods• Associated features (bloating, nausea)• Vaginal discharge• Other pain syndromes• Family history
CPP - Examination
• General - affect, weight• Abdominal• Speculum• Pelvic• Ultrasound
CPP - Investigations
• Swabs• MSU• Pelvic ultrasound• Laparoscopy +/- hysteroscopy• Cystoscopy (glomerulations, Hunner’s ulcers
in PBS), biopsy
IBS - Treatment
• Diet - food diary and exclusion, regular meals, hydration, caffeine elimination, limit fresh fruit
• Exercise• Probiotics (not prebiotics) minimum 4 weeks• Stress reduction• Antispasmodics - mebevarine, peppermint oil• Bulk forming laxatives - increase fluid intake• Antimotility drugs - loperamide• Tricyclic antidepressants• Complementary therapies• Psychological interventions
PID - Treatment
• Chlamydia - Azithromycin 1g stat PO and refer to STI clinic
• PID, polymicrobial - Ofloxacin 400mg bd and Metronidazole 400mg bd x 14 days
Severely ill patients;Doxycycline 100mg bd and Ceftriaxone 1g iv stat andMetronidazole 400mg tds
Interstitial Cystitis (PBS) - Treatment
• Bladder distention• Bladder instillation (dimethyl sulfoxide, DMSO)• Pentosan polysulfate (Elmiron) ?repairs defects in
bladder epithelium• Aspirin, ibuprofen• TENS• Lifestyle - diet, smoking, exercise• Bladder training• Surgery - fulguration, resection, augmentation,
cystectomy
Endometriosis
Introduction
Overview
Outline current treatment modalities
Explore evidence base for treatments
Present recommendations
Definition
“The presence of endometrial glands and stroma outside the uterine cavity”
• endometrial glands
• endometrial stroma
• fibrosis
• haemorrhage
Prevalence
Women with pelvic pain have a higher incidence of endometriosis (range: 40–80%) than women with infertility without pain (20–50%) or control groups (5–20%)
Koninckx et al, 1991
Prevalence increasing over the yearsGuo et al Gynecol Obstet Invest 2006
Pathology
Peritoneal inflammation and fibrosis
Adhesions
Ovarian cysts
Deep nodules
Symptomatology
Dysmenorrhea
Dyspareunia
Dyschezia / bowel symptoms / rectal bleeding
Non-cyclical pelvic pain
Urinary symptoms / haematuria
Associations
Menorrhagia (adenomyosis)
Subfertility
IBSPID Seaman et al BJOG 2008
Chronic pain syndromes
Depression - 86% vs 38%Lorencatto et al Acta Obsstet Gynecol Scand 2006
Pathogenesis
Retrograde menstruation / transplantation Sampson
Coelomic metaplasia Meyer
Metastasis (haematogenous / lymphatic) Javert
Genetic basis (Chr 7, 10, 20) Montgomery et al Hum Reprod 08
Immunologic basis
Susceptibility
Genetic predisposition Increased exposure to menstrual debris Abnormal eutopic endometrium Altered peritoneal environment Reduced immune surveillance Increased angiogenic capacity
Healy et al 1998; Vinatier et al 2001; Treloar et al 2002; Varma et al 2004
Natural history
Largely unknown
Average sx duration 7 yrs prior to diagnosis
Remitting / recurring
Hormonally-driven
Lifetime experience
Symptom duration 16 years
Half tried three / more medical treatments
Half had surgical procedures performed at least 3 times
One in five had hysterectomy / oophorectomy - most successful for sxs
Sinaii et al Fertil Steril 2007, 1998 Endometriosis Association Survey
Symptom-to-diagnosis lag
Confusion with other conditions
Co-existence with other conditions
Lack of awareness of and enquiry into symptomatology
Un / Mis - diagnosed at laparoscopy
Mechanisms of pain
Inflammatory cytokines in the peritoneal cavity
Focal bleeding from implants
Irritation and direct infiltration of nerves
Hormonal modulation: pain threshold
Mechanisms of subfertility
Distorted adnexal anatomy
Ovarian cysts
Adverse effects on folliculogenesis
Interference with oocyte/sperm survival, fertilization and embryogenesis
Endometriosis - diagnosis
QuickTime™ and aTIFF (Uncompressed) decompressor
are needed to see this picture.
QuickTime™ and aTIFF (Uncompressed) decompressor
are needed to see this picture.
QuickTime™ and aTIFF (Uncompressed) decompressor
are needed to see this picture.
QuickTime™ and aTIFF (Uncompressed) decompressor
are needed to see this picture.
VESICULAR LESIONS
PERITONEAL LESION WITH NEOVASCULARISATION AND FIBROSIS
VESICULAR LESIONS
TUBAL ENDOMETRIOSIS
“KISSING OVARIES”
PERITONEAL SCARRING
SUBDIAPHRAGMATIC ENDOMETRIOSIS
SUBDIAPHRAGMATIC SCARRING
ADHESION-LIKE APPEARANCE
RECTUM ADHERENT TO POD
Endometriosis - location Ovaries 60%
Tubes 21%
POD / pelvic sidewall 83%
Ureter 13%
Bowel 51%
Bladder 13%
Grading ofendometriosis
American Society for Reproductive Medicine (ASRM)
• Peritoneal disease• Ovarian disease• POD disease• Adhesions
Stage I-IV
Endometriosis - Grade vs Symptoms
Grade not directly correlated with symptomatology
Advanced disease more frequently related to dysmenorrhea and dyspareunia compared to early disease
Milingos et al Gynaeol Obstet Invest 2006
Endometriosis - what is the impact?Quality of life (EuroQOL, Health score, EHPQ-30)
Social functioning(SF36/12)
Sexual activity(SAQ)
Medical treatment
Medical management
Non-steroidal anti-inflammatory drugs
Inhibition of ovulation OCPGnRH agonistsDepo-Provera
Atrophy of endometriotic lesions / local effectOral progestogensDepo-proveraMirena
Oral analgaesics
NSAIDS inconclusive evidence for use Allen et al, Cochrane review 2005
Oral contraceptive pill
OCP effective for dysmenorrhea and reduced endometrioma size
Harada et al Fertil Steril 2007
OCP equivalent to GnRHCochrane Review 2007
Continuous OCP in women in whom recurrent dysmenorrhea not controlled by cyclical OCP
Vercellini et al Fertil Steril 2003
GnRH agonists
GnRH agonist use for endometriosis-related pain well-established
Dlugi et at Fertil Steril 1990, Waller et al Fertil Steil 1993, Henzl et al
NEJM 1988
GnRH agonists with or without add-back E work better than OCP for post-surgical relapse. Add-back improves QOL scores
Zupi et al Fertil Steril 2004
Progestogens
Oral progestogens poorly tolerated due to side-effects
Depo-provera equivalent to GnRH for pain scores.Less loss of bone mineral density with DMPA Schlaff et al Fertil Steril 2006
Mirena
70% symptomatic relief after 12 monthsVercellini et al 1999
Radiographic evidence of regression of rectovaginal lesionsFedele et al 2001
Improvement in severity and frequency of pain and menstrual sxs, and staging of diseaseLockhat et al Hum Reprod 2004
Mirena equivalent to GnRH for painPetta et al Hum Reprod 2005
Surgical treatment
Surgery for endometriosis
Ablation / excision of superficial peritoneal deposits
Excision of deep peritoneal deposits
Stripping / drainage and ablation of endometriomata
Hysterectomy / Oophorectomy
Extent of surgery - tertiary unit
Total laparoscopic hysterectomy 8%
Resection endometriosis 81%
Ureterolysis 51%
Bowel dissection 57%
Ablation of endometrioma(s) 10%
Stripping of endometrioma(s) 30%
Operative time (mins) med (IQR, R) (90-162) (20-270)
Blood loss (ml) med (IQR, R) (100-500) (50-2000)
Hospital stay (days) med, (IQR, R) (2-4) (1-8)
Evidence for surgical treatment
Ablation of endometriosis
Laser ablation superior to expectant mgt 62% vs 25% clinical response at 6/12
Sutton et al Fertil Steril 1994
Helica thermal coagulation - 87% response at 6/12Nardo et al Fertil Steril 2005
LUNA has no effect on endometriosis-related dysmenorrhea
Vercellini et al Fertil Steril 2003
Excision of deep endometriosis
Lap excision superior to placebo for pain and QOL Abbott et al Fertil Steril 2004
Symptoms, QOL and sexual function improved after excisional surgery
Garry et al, Anaf et al, Redwine et al, Ford et al, Lyons et al, Dubernard et al, Wykes et al
Treatment of endometriomas
Stripping vs drainage and ablation of endometriomas reduces pain symptoms and recurrence
Hart et al Fertil Steril 2005, Cochrane Review
Hysterectomy / Oophorectomy
Hysterectomy associated with high rate of symptom resolution and low re-operation rate
Shakiba et al Obstet Gynecol 2008
Ovarian conservation associated with increased risk of recurrent pain (x 6) and re-operation rate (x 8)
Namnoun et al Fertil Steril 1995
Complications of surgery
Complications of laparoscopy
Organ injury
ureter
bowel
bladder
Bleeding
Adhesion prevention in endometriosis surgerySuturing of ovary decreases adhesion formationPellicano et al Fertil Steril 2008
Adhesion prevention agentsBarrier Interceed reduces adhesions
Cochrane 2008
Fluid Limited evidence Cochrane 2006
Icodextrin 4% (Adept) reduces adhesions
Brown et al Fertil Steril 2007
Surgery - outcomesMean pre-op VAS scores
Mean post-op VAS scores
(Med FU 6/12)
Improvement in mean scores
p-value
Period pain 8 4.5 2.5 <0.001
Pelvis pain 5 2 3 <0.001
Sexual intercourse pain
4 2 2 0.001
Pain opening bowels
5 1 4 <0.001
Health scores 64 80 16 <0.001
EUROQOL (Health state)
0.73 0.80 0.07 0.003
SF-12
Physical 46 52 6 0.074
Mental 41 49 7 <0.001
Evidence for surgery Pain and QOLImprovement in pain, SAQ and QOL scores up
to 5 years • Placebo response rate 30% • Non-responsiveness to surgery 20%
Ford et al 2004; Abbott et al 2003 & 2005
LUNA is not effective in this group Johnson et al 2005
Evidence for surgery - FertilityLaparoscopic ablation of minimal/mild endo
improves fertility Marcoux et al NEJM 1997, Cochrane Review 2002
Endometrioma excisionOvulation rate in natural cycles reduced compared with pre-opHorikawa et al, J Assist Reprod Genet 2008
Ovarian response in IVF-ET cycles reduced
Yazbeck et al, Gynecol Obstet Fertil 2006
Post-operative treatment
Post-op continuous OCP and POP useful Razzi et al Eur J Obstet Gynaecol Rep Biol 2007
Postoperative GnRH improved pain when used for 3/12 and 6/12
Parazzini et al Am J Obstet Gynecol 1994, Vercellini et al BJOG 1999
Post-op Mirena useful Abbou Setta et al Cochrane Review 2006
Post-operative treatment
Post-operative hormonal suppression (COCP or GnRH) reduces dysmenorrhea vs placebo
Dietary supplementation improves non-menstrual pain post-operatively as much as OCP
Quality of life scores better with hormonal suppression
Sesti et al Fertil Steril 2007
Endometriosis recurrence
30% recurrence of endometriomata 2 years after surgical excision
Koga et al Hum Reprod 2006
Re-operation rate 35% after 3 yearsAbbott et al 2005
Multidisciplinary management of endometriosisAssociated with decrease in pain, anxiety,
depression in CPP groupKames et al Pain 1990
Integrated approach improved pain significantly more than standard approach with CPP
Peters et al Obstet Gynecol 1991
Complementary therapies and endometriosisAcupuncture; Japanese-style acupuncture vs sham acupunctureWayne et at J Paed Adolesc Gynecol
Shu Mu vs standard vs danazol on clinical sxs and CA125
Sun et al, Zhongguo Zhen Jiu 2006
Traditional Chinese medicine; Neiyi pill / enema vs danazol x 3/12 on CA125
levelsLu et al Zhongguo Zhen Jiu, 2007
ESHRE guideline
Laparoscopy desirable for women presenting with sxs of endometriosis
Therapeutic trial of hormonal agents may be used first line
Laparoscopically-diagnosed endometriosis treated for 6/12 with ovarian suppression drug
ESHRE guideline
• Inconclusive evidence that NSAIDS (Naproxen) efffective
• Suppression of ovarian function for 6/12 reduces endometriosis-related pain. All hormonal drugs equally effective but side-effect and cost profiles differ
• LNG-IUS reduces pain
• GnRH treatment for up to 2 years with E/P addback acceptable
ESHRE guideline
• Ideal practice is to diagnose and remove endometriosis at the same time provided consent has been obtained
• Ablation of endometriosis reduces pain, less so with mild disease
• No evidence that LUNA is effective
• Excision of deeply-infiltrating lesions reduces pain
• Severe / deeply infiltrating endometriosis should be referred to a centre with expertise
ESHRE guideline
• Suppression of ovarian function not effective to enhance fertility
• Insufficient evidence that excision of moderate-severe endometriosis enhances pregnancy rates
Future treatments for endometriosisPresacral neurectomy
Mifepristone (anti-progesterone)
Aromatase inhibitors (anastrozole, letrozole)
TNF alpha inhibitors
Thalidomide
THANK YOU